Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Gossamer Bio (GOSS) over the last 6 years, with Dec 2024 value amounting to -$0.25.

  • Gossamer Bio's EPS (Weighted Average and Diluted) fell 50.00% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.69, marking a year-over-year decrease of 165.38%. This contributed to the annual value of -$0.25 for FY2024, which is 78.81% up from last year.
  • As of FY2024, Gossamer Bio's EPS (Weighted Average and Diluted) stood at -$0.25, which was up 78.81% from -$1.18 recorded in FY2023.
  • In the past 5 years, Gossamer Bio's EPS (Weighted Average and Diluted) ranged from a high of -$0.25 in FY2024 and a low of -$3.55 during FY2020.
  • Over the past 3 years, Gossamer Bio's median EPS (Weighted Average and Diluted) value was -$1.18 (recorded in 2023), while the average stood at -$1.38.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first declined by 7.90% in 2020, then surged by 78.81% in 2024.
  • Over the past 5 years, Gossamer Bio's EPS (Weighted Average and Diluted) (Yearly) stood at -$3.55 in 2020, then increased by 11.83% to -$3.13 in 2021, then climbed by 13.42% to -$2.71 in 2022, then skyrocketed by 56.46% to -$1.18 in 2023, then soared by 78.81% to -$0.25 in 2024.